| 英文名称 |
中文名称 |
CAS |
|
Losartan EP Impurity K
|
|
114798-36-6 |
|
Imatinib Impurity 12
|
|
404844-11-7 |
|
9α Br Hydrocortisone Acetate
|
|
50733-54-5 |
|
5-Vinylbenzo[d][1,3]dioxole
|
|
7315-32-4 |
|
Losartan EP Impurity C
|
|
114799-13-2 |
|
Levofloxacin EP Impurity G HCl
|
|
1346603-62-0 |
|
Hydroxychloroquine EP Impurity C
|
|
4298-15-1 |
|
Hydroxychloroquine O-Acetate
|
|
47493-14-1 |
|
5-Chloro-6-(1-piperidinyl)-2,4-pyrimidinediamine
|
|
1784008-01-0 |
|
Diethyl (2-Oxo-2-phenylethyl)phosphonate
|
|
3453-00-7 |
|
Benzo[k]fluoranthene
|
|
207-08-9 |
|
N-Fmoc-1-amino-2-methyl-2-propanol
|
|
1466611-97-1 |
|
Isothipendyl HCl
|
|
1225-60-1 |
|
Levosimendan Impurity 6
|
|
220246-81-1 |
|
Isopropyl2-bromopropanoate
|
|
7401-84-5 |
|
2,4-Diamino-5,6-dichloropyrimidine
|
|
89033-89-6 |
|
DL-Carnitine
|
|
406-76-8 |
|
Lurasidone Opened Imide
|
|
1644295-07-7 |
|
Ibrutinib Dimer Impurity
|
|
2031255-23-7 |
|
5,6-trans-Latanoprost
|
|
913258-34-1 |
|
(6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one 7,7-dioxide
|
|
148719-91-9 |
|
Levomedetomidine
|
|
119717-21-4 |
|
Lamotrigine EP Impurity G
|
|
38943-76-9 |
|
Glibenclamide EP Impurity D
|
|
38160-73-5 |
|
Lidocaine EP Impurity J HCl
|
|
1012864-23-1 |
|
Linagliptin Methyl Dimer
|
|
1418133-47-7 |
|
2-Bromo-3-fluoro-4-iodo-pyridine
|
|
1804910-90-4 |
|
Cetirizine EP Impurity D
|
|
346451-15-8 |
|
Hydrocortisone Valerate
|
|
57524-89-7 |
|
(2R,5R)-2,5-Diphenylpyrrolidine
|
|
155155-73-0 |
|
Levothyroxine EP Impurity H
|
|
2055-97-2 |
|
2-Hydroxy-1,4-benzoquinone
|
|
2474-72-8 |
|
beta-Aspartyl-Aspartic Acid
|
|
60079-22-3 |
|
N-Boc Linagliptin
|
|
668273-75-4 |
|
Linezolid N-Oxide
|
|
189038-36-6 |
|
Medroxyprogesterone Acetate EP Impurity I
|
|
|
|
(S)-Levetiracetam EP Impurity A
|
|
102849-49-0 |
|
Levosimendan Dimer
|
|
618458-79-0 |
|
Levetiracetam EP Impurity A
|
|
67118-31-4 |
|
Imatinib EP impurity C
|
|
404844-02-6 |
|
(3b,5b,15a,16a)-15,16-Dihydro-3,5-dihydroxy-3'H-cycloprop[15,16]androsta-6,15-dien-17-one
|
|
82543-15-5 |
|
Latanoprost Acid
|
|
41639-83-2 |
|
Goserelin EP Impurity K Acetate
|
|
|
|
(R)-Licarbazepine Acetate
|
|
186694-45-1 |
|
Lidocaine Dichloro Impurity
|
|
39084-88-3 |
|
Scopolamine EP Impurity B
|
|
535-26-2 |
|
2-Chloro-1-(p-tolyl)ethanone
|
|
4209-24-9 |
|
Hydroxychloroquine EP Impurity D
|
|
1476-52-4 |
|
Isothipendyl Impurity 1 HCl
|
|
132962-42-6 |
|
Latanoprost Lactone Diol
|
|
145667-75-0 |
|
1,3-Dibromo-5-(tert-butyl)-2-nitrobenzene
|
|
2828612-34-4 |
|
2,4-Diamino-5-chloro-6-piperidine pyrimidine-3-oxide
|
|
2889432-05-5 |
|
(R)-Ketorolac
|
|
66635-93-6 |
|
(15S)-Latanoprost
|
|
145773-22-4 |
|
N,N'-Diphenylethylenediamine
|
|
150-61-8 |
|
Methyl4-bromo-6-chloronicotinate
|
|
1256790-93-8 |
|
Loxoprofen Ring-opening Impurity
|
|
1091621-61-2 |
|
Lidocaine EP Impurity D HCl
|
|
7729-94-4 |
|
15-Keto Latanoprost
|
|
135646-98-9 |
|
Indapamide EP Impurity B
|
|
63968-75-2 |
|
Hydrocortisone Acetate EP Impurity E
|
|
7753-60-8 |
|
Imatinib EP Impurity D Chloride
|
|
1821122-73-9 |
|
Lansoprazole EP Impurity F
|
|
168167-42-8 |
|
Imatinib EP impurity J
|
|
571186-91-9 |
|
(S)-Ketorolac
|
|
66635-92-5 |
|
Lisinopril EP Impurity F
|
|
1132650-67-9 |
|
Ketorolac EP Impurity B
|
|
113502-52-6 |
|
Levothyroxine Acetamide Impurity
|
|
176258-88-1 |
|
Lidocaine EP Impurity G HCl
|
|
35891-87-3 |
|
Ibrutinib Addition Adduct
|
|
1987905-93-0 |
|
2,4-Diamino-5,6-dichloropyrimidine 3-oxide
|
|
35139-68-5 |
|
Linagliptin N-Acetyl Impurity
|
|
1803079-49-3 |
|
Latanoprost EP Impurity D
|
|
2088449-88-9 |
|
3,4,5-Tris(benzyloxy)benzyl Alcohol
|
|
79831-88-2 |
|
Lurasidone Aminomethyl Impurity DiHCl
|
|
1260025-93-1 |
|
Imatinib EP Impurity B
|
|
581076-65-5 |
|
Isononylphenol
|
|
11066-49-2 |
|
Exodiene Lurasidone
|
|
3024924-65-7 |
|
Lidocaine EP Impurity K HCl
|
|
50295-20-0 |
|
Lansoprazole Thioxo Impurity
|
|
1246819-06-6 |
|
Ethyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate
|
|
1260672-33-0 |
|
Lidocaine EP Impurity I HCl
|
|
17289-54-2 |
|
(S)-Linagliptin
|
|
668270-11-9 |
|
Ibrutinib Diamide Impurity
|
|
2031255-27-1 |
|
Hydralazine Triazolo Methyl Impurity
|
|
20062-41-3 |
|
Cyclo(-Ala-Gln)
|
|
268221-76-7 |
|
Ibuprofen Impurity 19/4-(1-Carboxy-ethyl)-Benzoic Acid
|
|
67381-50-4 |
|
Lacosamide EP Impurity B
|
|
1318777-54-6 |
|
Hydrocortisone EP Impurity M
|
|
566-35-8 |
|
Lercanidipine Acid
|
|
855592-30-2 |
|
Linagliptin Impurity 31
|
|
2253964-85-9 |
|
Ibuprofen EP Impurity N
|
|
3585-52-2 |
|
Ibrutinib N-Oxide
|
|
2417548-74-2 |
|
(2R,3R,4R,5S)-2,3,4,5,6-pentahydroxyhexyl 4-hydroxybenzoate and (2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl 4-hydroxybenzoate
|
|
|
|
2-Propenylpropylpropanedioic Acid Diethyl Ester
|
|
59726-38-4 |
|
Lidocaine EP Impurity F HCl
|
|
857170-72-0 |
|
ent-Lurasidone
|
|
1448443-35-3 |
|
N-Desmethyl Ibandronate
|
|
905808-25-5 |
|
(S)-Licarbazepine
|
|
104746-04-5 |
|
N-Methyl-N’-nitrosopiperazine
|
|
16339-07-4 |
